Latest lung disease News

Enhertu approved in US as first HER2-directed therapy for patients with HER2-low metastatic breast cancer
Recruitment open for new study of lung disease
Enhertu granted Priority Review in US for patients with HER2-low metastatic breast cancer
AMA calls out Premier Palaszczuk for lack of consultation on pharmacy trial
QLD Premier must consult on pharmacy prescribing trial
Australia’s first national biotechnology incubator announces round one funding
Enhertu approved in EU for patients with HER2-positive metastatic breast cancer treated with one or more prior anti-HER2-based
Cynata Therapeutics secures US patent for Use of Cymerus MSCs in Asthma
Curtin University study backs AWU’s alarm at extent of workplace silicosis health risk
Mobile Health Unit at Opal Festival
Inhalable Covid Vaccine Shows Promise in Rodent Model
Top 3 questions – Oral Treatments for Covid with Dr Lucas de Toca
New drug target identified for inflammatory lung disease
Nuclear medicine funding a win for men with prostate cancer
Consultation Regulation Impact Statement: Managing risks of respirable crystalline silica at work
COPD patients respond equally well to Covid vaccine
Union shuts down major transmission line project to protect workers
Monash mRNA projects get funding boost
Addressing e-cigarette use among school children
New projects announced for National Drug Discovery Centre
Treatment hope for premature babies
Chronic lung disease treatment hits speed bump
Faster Diagnosis Possible In New Clinical Trial
Sleep relief for lung disease
Seventy-fifth World Health Assembly – Daily update 28 May
Influenza and Covid vaccination provide important protection this winter
Top 3 with Dr Lucas De Toca – Winter Preparedness
RACGP welcomes winter Covid booster expansion
Pandemic Science Hub to fight lung disease
PT027, novel fixed-dose combination of albuterol and budesonide, used as an as-needed rescue medicine
Cochrane Review highlights need for new interventions to improve chronic obstructive pulmonary disease
New VIC regulations against silicosis should be rolled out nationwide
Leveraging science of hibernation to improve human heart health
Weill Cornell instills social justice, health equity in medical education
$10 million investment fuels promising treatments for inflammatory lung disease
Researcher founding scientist of new biotech company launched with AUD$10m investment
32% more deaths at work under Morrison since 2018
Beyond emergencies: Researchers rethink role of paramedics in health system
Lack of universal dental care hole that can be fixed
Melioidosis cases on rise
WHO, Ghana and Norway agree to accelerate actions to save lives
ACT construction must improve silicosis control measures
Health and environment
Time to shift research focus from ‘bikini medicine’ to what is really ailing women
Expanded PBS listing for lung disease medication
New global guidelines to manage childhood TB
Top 3 questions – Healthy lifestyle choices
Update on US regulatory review of Fasenra in chronic rhinosinusitis with nasal polyps